Number of Shares
42.88 Mil
Current Holdings Value*
$712.20 Mil
% of Portfolio
7.97%
Total Estimate Gain
$177.24 Mil
% of Total Estimate Gain
21.66%

BAKER BROS. ADVISORS LP's ACADIA Pharmaceuticals Inc Holding Summary

As of 2025-03-31, BAKER BROS. ADVISORS LP held 42.88 Mil shares of ACADIA Pharmaceuticals Inc(ACAD), totaling $712.20 Mil. This investment constitutes 7.97% of their stock portfolio, and BAKER BROS. ADVISORS LP now holds 25.62% of the outstanding ACADIA Pharmaceuticals Inc(ACAD) stock.

The initial trade took place in 2013Q2. And since then BAKER BROS. ADVISORS LP has made 14 purchases of ACAD, at an average price of $18.90, for a total of 43.30 Mil shares. In addition, there have been 1 sales at an average price of $25.52 for 421,756.00 shares. Based on historical transaction data and ACAD's current price of $22.97, BAKER BROS. ADVISORS LP's estimated gain on his ACAD holdings is $177.24 Mil, reflecting a 21.66% gain to date.

BAKER BROS. ADVISORS LP ACAD ($22.97) Holding Chart

BAKER BROS. ADVISORS LP ACAD ($22.97) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1